Funding for this research was provided by:
Capital’s Funds for Health Improvement and Research (2018-2-1022)
Beijing Municipal Science and Technology Commission NOVA Program (2010 B033)
Beijing Municipal Science and Technology Commission Capital Characteristic Clinical Application Research (Z141107002514077)
National Natural Science Foundation of China (61501039)
Beijing Cancer Hospital (13-11)
Received: 24 October 2019
Accepted: 6 February 2020
First Online: 11 May 2020
Ethics approval and consent to participate
: Written informed consent from all the patients and approval from the Ethics Committee of the Peking University Cancer Hospital were obtained.
: Not applicable.
: The authors declare that they have no competing interests.